Antidepressants for smoking cessation: A promising new approach?

European Respiratory Journal

Volumn 16, Issue 3, 2000, Pages 379-380

  Huibers, M J H ^a   Chavannes, N H ^a   Wagena, E J ^a   Van Schayck, C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NICOTINE; NORTRIPTYLINE;

ATTITUDE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; EDITORIAL; EUROPE; FOOD AND DRUG ADMINISTRATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; SMOKING CESSATION; STATISTICAL ANALYSIS; SUPPORT GROUP; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; HUMAN; SELF-HELP GROUPS; SMOKING CESSATION;

EID: 0033796821     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.016003379.x     Document Type: Editorial

References (7)

1. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling
2. An analysis of the effectiveness of interventions intended to help people stop smoking
3. Pharmacotherapy of smoking cessation
4. A comparison of sustained-release bupropion and placebo for smoking cessation
5. A controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation
6. A randomized trial of nortriptyline for smoking cessation
7. Nortriptyline and cognitive-behavioral therapy in the treatment of smoking cessation